Determining the risks of clinically indicated nonthoracic magnetic resonance imaging at 1.5 T for patients with pacemakers and implantable cardioverter-defibrillators: rationale and design of the MagnaSafe Registry.
about
MRI for patients with cardiac implantable electrical devices.Safe performance of magnetic resonance of the heart in patients with magnetic resonance conditional pacemaker systems: the safety issue of the ESTIMATE studyMagnetic resonance imaging in patients with a subcutaneous implantable cardioverter-defibrillatorCardiac MRI of patients with implanted electrical cardiac devices.MRI-conditional pacemakers: current perspectives.Republished: Cardiac MRI of patients with implanted electrical cardiac devices.Provision of magnetic resonance imaging for patients with 'MR-conditional' cardiac implantable electronic devices: an unmet clinical need.Safety of implanted cardiac devices in an MRI environment.Safe use of MRI in people with cardiac implantable electronic devices.Cardiovascular implantable electronic devices: a review of the dangers and difficulties in MR scanning and attempts to improve safety.Safely assessing radiofrequency heating potential of conductive devices using image-based current measurements.Real world MRI experience with nonconditional and conditional cardiac rhythm devices after MagnaSafe.Clinical Performance of Magnetic Resonance Imaging Conditional and Nonconditional Cardiac Implantable Electronic Devices.Issues with radiofrequency heating in MRI.Issues with radiofrequency heating in MRI.Optimized cardiac magnetic resonance imaging inversion recovery sequence for metal artifact reduction and accurate myocardial scar assessment in patients with cardiac implantable electronic devices
P2860
Q33569982-E78D6DDA-4205-4478-9782-BCF933011595Q33631682-F68869A8-C5E6-4DFE-B27E-62076A7F2CEEQ35550970-C2EB7B08-DE21-44EB-B54F-8F7B6AB67357Q38123003-8C76E774-F24C-405F-8E5A-7899813F497EQ38213706-EB81B3EC-4B0C-466C-A2AF-7B26C9656CD5Q38272265-C49D7C9D-71AF-410D-B249-9C8E40947C4CQ38413818-91FB18FF-4662-46DC-8DA9-B5551897C482Q38508944-6C341B82-2B5A-4772-A9DC-F516A41E4D70Q38595564-3F043A1C-D02D-43C3-A3F8-DB3975BD99C0Q39380514-A82D6AED-0BA9-4182-BAF7-5250C296D289Q44810031-6C5B5699-C413-4678-98F5-B850349DE67DQ47619655-1C3C65EF-769C-4F8E-B360-978AD0F01AD3Q50995028-4F4BAE05-062C-4CAD-A8E3-E04CDC16091BQ53450714-C9890A3E-6056-4EFF-8565-5A432FE2D1C3Q54956652-D7ABC45A-4B89-470A-A61C-DD6320A50EFAQ57490641-57889A10-AD31-417A-AFFA-C755ACF11ED4
P2860
Determining the risks of clinically indicated nonthoracic magnetic resonance imaging at 1.5 T for patients with pacemakers and implantable cardioverter-defibrillators: rationale and design of the MagnaSafe Registry.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Determining the risks of clini ...... ign of the MagnaSafe Registry.
@en
Determining the risks of clini ...... ign of the MagnaSafe Registry.
@nl
type
label
Determining the risks of clini ...... ign of the MagnaSafe Registry.
@en
Determining the risks of clini ...... ign of the MagnaSafe Registry.
@nl
prefLabel
Determining the risks of clini ...... ign of the MagnaSafe Registry.
@en
Determining the risks of clini ...... ign of the MagnaSafe Registry.
@nl
P1476
Determining the risks of clini ...... ign of the MagnaSafe Registry.
@en
P2093
Robert J Russo
P304
P356
10.1016/J.AHJ.2012.12.004
P407
P577
2013-01-28T00:00:00Z